S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:HALO

Halozyme Therapeutics SEC Filings & 10K Form

$40.91
+0.50 (+1.24 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$38.81
Now: $40.91
$41.03
50-Day Range
$40.41
MA: $48.07
$51.45
52-Week Range
$12.71
Now: $40.91
$56.40
Volume2.10 million shs
Average Volume1.55 million shs
Market Capitalization$5.53 billion
P/E Ratio255.69
Dividend YieldN/A
Beta1.77

SEC Filings

Halozyme Therapeutics (NASDAQ:HALO) SEC Filings

DateFilerForm TypeView
03/02/2021
6:15 PM
Halozyme Therapeutics (Issuer)
Sun Elaine D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:08 PM
Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:06 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:03 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
5:06 AM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2021
3:16 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2021
3:12 PM
Halozyme Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2021
5:28 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:27 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
4:05 PM
Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
4:04 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
4:03 PM
Halozyme Therapeutics (Issuer)
Sun Elaine D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
4:02 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
6:10 PM
Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
6:07 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
6:06 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
9:57 AM
Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/10/2021
5:17 AM
Artisan Partners Limited Partnership (Filed by)
Halozyme Therapeutics (Subject)
Form SC 13G/A
02/01/2021
5:56 PM
Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
5:55 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
1:22 PM
BlackRock Inc. (Filed by)
Halozyme Therapeutics (Subject)
Form SC 13G/A
01/13/2021
4:11 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2021
7:07 AM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
4:07 PM
Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
5:01 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2020
3:56 PM
BlackRock Inc. (Filed by)
Halozyme Therapeutics (Subject)
Form SC 13G
12/07/2020
5:05 PM
Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
4:55 PM
Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2020
6:57 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2020
4:43 PM
Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
5:59 PM
Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
5:57 PM
Daly James M (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
5:56 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2020
5:25 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
3:11 PM
Halozyme Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2020
3:04 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2020
3:53 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2020
6:30 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
4:33 PM
Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2020
5:13 PM
Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
3:21 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
5:43 PM
Daly James M (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
3:03 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2020
5:33 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:39 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
3:11 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:09 PM
Halozyme Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2020
6:15 PM
Halozyme Therapeutics (Issuer)
Posard Matthew L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2020
6:14 PM
Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2020
6:12 PM
Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2020
6:12 PM
Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2020
6:11 PM
Daly James M (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2020
6:10 PM
Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2020
6:09 PM
BIZZARI JEAN-PIERRE (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
8:42 AM
Artisan Partners Limited Partnership (Filed by)
Halozyme Therapeutics (Subject)
Form SC 13G
04/03/2020
7:03 AM
Halozyme Therapeutics (Filer)
Form DEFA14A
03/19/2020
6:28 PM
Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
7:04 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
7:03 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
7:02 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
3:16 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
3:15 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
5:41 PM
Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
5:39 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
5:38 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
5:24 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:05 PM
Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:03 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
4:59 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
4:56 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
1:24 PM
Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/10/2020
12:41 PM
Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/04/2020
3:11 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/28/2020
8:56 AM
Halozyme Therapeutics (Subject)
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by)
Form SC 13G/A
01/16/2020
3:25 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
3:23 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
4:02 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
5:06 AM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:15 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
3:53 PM
Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
Form SC 13D/A
11/05/2019
3:36 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
6:10 PM
Halozyme Therapeutics (Issuer)
Hickey Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
10:20 AM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:18 PM
Halozyme Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
7:11 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:01 PM
Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
Form SC 13D/A
06/17/2019
7:19 AM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
12:40 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
4:10 PM
Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
Form SC 13D/A
06/03/2019
4:22 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
4:10 PM
Halozyme Therapeutics (Filer)
Form S-8 POS
05/07/2019
3:08 PM
Halozyme Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
3:01 PM
Armour Alison A. (Reporting)
Halozyme Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/03/2019
4:05 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
3:23 PM
Halozyme Therapeutics (Issuer)
Posard Matthew L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
3:20 PM
Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
3:12 PM
Daly James M (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
3:10 PM
Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2019
3:08 PM
Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
3:07 PM
Halozyme Therapeutics (Filer)
Form DEF 14A
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.